San Francisco, CA, United States of America

Ellen S Yetzer

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Hoffmann-La Roche Inc., Pharmasset, Inc., Roche Palo Alto LLC. Active years: 2014.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ellen S Yetzer: Innovator in Hepatitis C Treatment

Introduction

Ellen S Yetzer is a notable inventor based in San Francisco, CA, recognized for her contributions to the field of medical therapeutics. She has developed innovative solutions aimed at treating hepatitis C virus infections, showcasing her expertise in pharmaceutical compositions.

Latest Patents

Ellen S Yetzer holds 1 patent for a therapeutic composition that includes a hepatitis C viral polymerase inhibitor and a hepatitis C viral protease inhibitor. The embodiments disclosed in her patent relate to methods for treating conditions such as hepatitis C virus infection, liver fibrosis, and impaired liver function. This innovative approach highlights her commitment to advancing medical treatments for viral infections.

Career Highlights

Throughout her career, Ellen has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Pharmasset, Inc. Her experience in these organizations has contributed significantly to her development as an inventor and her understanding of the complexities involved in drug formulation and therapeutic applications.

Collaborations

Ellen has collaborated with esteemed colleagues such as Steven B Porter and Williamson Ziegler Bradford. These partnerships have likely enriched her research and development efforts, fostering an environment of innovation and shared knowledge.

Conclusion

Ellen S Yetzer's work in developing therapeutic compositions for hepatitis C treatment exemplifies her dedication to improving healthcare outcomes. Her innovative contributions continue to impact the field of medicine positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…